1. Home
  2. KALA vs PMEC Comparison

KALA vs PMEC Comparison

Compare KALA & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • PMEC
  • Stock Information
  • Founded
  • KALA 2009
  • PMEC 1984
  • Country
  • KALA United States
  • PMEC Singapore
  • Employees
  • KALA 43
  • PMEC N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • PMEC
  • Sector
  • KALA Health Care
  • PMEC
  • Exchange
  • KALA Nasdaq
  • PMEC Nasdaq
  • Market Cap
  • KALA 27.3M
  • PMEC 25.9M
  • IPO Year
  • KALA 2017
  • PMEC 2023
  • Fundamental
  • Price
  • KALA $5.92
  • PMEC $0.68
  • Analyst Decision
  • KALA Strong Buy
  • PMEC
  • Analyst Count
  • KALA 2
  • PMEC 0
  • Target Price
  • KALA $15.00
  • PMEC N/A
  • AVG Volume (30 Days)
  • KALA 31.3K
  • PMEC 71.9K
  • Earning Date
  • KALA 11-12-2024
  • PMEC 12-31-2024
  • Dividend Yield
  • KALA N/A
  • PMEC N/A
  • EPS Growth
  • KALA N/A
  • PMEC N/A
  • EPS
  • KALA N/A
  • PMEC N/A
  • Revenue
  • KALA N/A
  • PMEC $72,524,000.00
  • Revenue This Year
  • KALA N/A
  • PMEC N/A
  • Revenue Next Year
  • KALA N/A
  • PMEC N/A
  • P/E Ratio
  • KALA N/A
  • PMEC N/A
  • Revenue Growth
  • KALA N/A
  • PMEC 5.07
  • 52 Week Low
  • KALA $4.21
  • PMEC $0.49
  • 52 Week High
  • KALA $9.25
  • PMEC $4.15
  • Technical
  • Relative Strength Index (RSI)
  • KALA 41.69
  • PMEC 42.34
  • Support Level
  • KALA $5.67
  • PMEC $0.66
  • Resistance Level
  • KALA $6.23
  • PMEC $0.79
  • Average True Range (ATR)
  • KALA 0.31
  • PMEC 0.08
  • MACD
  • KALA -0.07
  • PMEC -0.01
  • Stochastic Oscillator
  • KALA 21.55
  • PMEC 14.62

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

Share on Social Networks: